Key result
Betatrophin knockdown lowers white fat and plasma TG/NEFA levels, inducing adipocyte beiging via AMPK activation.
Why the study?
Betatrophin has been linked to energy expenditure and lipolysis, but how it modulates beiging and adiposity remains unclear.
Does betatrophin knockdown induce beiging and mitochondria biogenesis in white adipocytes?
Does betatrophin knockdown induce beiging and mitochondria biogenesis in white adipocytes?
Downregulation of betatrophin induces beiging in white adipocytes through the AMPK signaling pathway, suggesting it as a potential therapeutic target for obesity.
May inform adipokine-targeted obesity research; hypothesis-generating in animals and leaves clinical translation open.
Remodeling of energy-storing white fat into energy-consuming beige fat has led to a promising new approach to alleviate adiposity. Several studies have shown adipokines can induce white adipose tissue (WAT) beiging through autocrine or paracrine actions. Betatrophin, a novel adipokine, has been linked to energy expenditure and lipolysis but not clearly clarified. Here, we using high-fat diet-induced obesity to determine how betatrophin modulate beiging and adiposity. We found that betatrophin-knockdown mice displayed less white fat mass and decreased plasma TG and NEFA levels. Consistently, inhibition of betatrophin leads to the phenotype change of adipocytes characterized by increased mitochondria contents, beige adipocytes and mitochondria biogenesis-specific markers both in vivo and in vitro. Of note, blocking AMP-activated protein kinase (AMPK) signaling pathway is able to abolish enhanced beige-like characteristics in betatrophin-knockdown adipocytes. Collectively, downregulation of betatrophin induces beiging in white adipocytes through activation of AMPK signaling pathway. These processes suggest betatrophin as a latent therapeutic target for obesity.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2020) studied Obesity. Betatrophin knockdown vs. Control was evaluated on White fat mass, plasma TG and NEFA levels, and adipocyte beiging. Betatrophin knockdown decreased white fat mass and plasma TG/NEFA levels, and induced beiging in white adipocytes through activation of the AMPK signaling pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: